• Home
  • Search Results
  • Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.

Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.

Molecular and cellular biology (2016-01-27)
Yuliya V Katlinskaya, Kanstantsin V Katlinski, Audrey Lasri, Ning Li, Daniel P Beiting, Amy C Durham, Ting Yang, Eli Pikarsky, Christopher J Lengner, F Brad Johnson, Yinon Ben-Neriah, Serge Y Fuchs
ABSTRACT

Wnt pathway-driven proliferation and renewal of the intestinal epithelium must be tightly controlled to prevent development of cancer and barrier dysfunction. Although type I interferons (IFN) produced in the gut under the influence of microbiota are known for their antiproliferative effects, the role of these cytokines in regulating intestinal epithelial cell renewal is largely unknown. Here we report a novel role for IFN in the context of intestinal knockout of casein kinase 1α (CK1α), which controls the ubiquitination and degradation of both β-catenin and the IFNAR1 chain of the IFN receptor. Ablation of CK1α leads to the activation of both β-catenin and IFN pathways and prevents the unlimited proliferation of intestinal epithelial cells despite constitutive β-catenin activity. IFN signaling contributes to the activation of the p53 pathway and the appearance of apoptotic and senescence markers in the CK1α-deficient gut. Concurrent genetic ablation of CK1α and IFNAR1 leads to intestinal hyperplasia, robust attenuation of apoptosis, and rapid and lethal loss of barrier function. These data indicate that IFN play an important role in controlling the proliferation and function of the intestinal epithelium in the context of β-catenin activation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
D4476, ≥98% (HPLC), solid

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.